Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma.

Baptista MJ, Tapia G, Morgades M, Muncunill J, Muñoz-Marmol AM, Montoto S, Gribben JG, Calaminici M, Martinez A, Gonzalez-Farre B, Dlouhy I, González-Barca E, Terol MJ, Miralles P, Alcoceba M, Vall-Llovera F, Briones J, Abrisqueta P, Abella E, Provencio M, García-Ballesteros C, Moraleda JM, Sancho JM, Ribera JM, Mate JL, Navarro JT.

Leuk Lymphoma. 2018 Oct 15:1-5. doi: 10.1080/10428194.2018.1512711. [Epub ahead of print] No abstract available.

PMID:
30322315
2.

Reply to Lupo et al.

Navarro JT, Muncunill J, Garcia O, Hernández-Rodríguez Á, Baptista MJ.

Clin Infect Dis. 2019 Feb 15;68(5):892-893. doi: 10.1093/cid/ciy788. No abstract available.

PMID:
30204856
3.

Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related Lymphomas.

Muncunill J, Baptista MJ, Hernandez-Rodríguez Á, Dalmau J, Garcia O, Tapia G, Moreno M, Sancho JM, Martínez-Picado J, Feliu E, Mate JL, Ribera JM, Navarro JT.

Clin Infect Dis. 2019 Feb 15;68(5):834-843. doi: 10.1093/cid/ciy542.

PMID:
29982484
4.

In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma.

Pérez-Salvia M, Aldaba E, Vara Y, Fabre M, Ferrer C, Masdeu C, Zubia A, Sebastian ES, Otaegui D, Llinàs-Arias P, Rosselló-Tortella M, Berdasco M, Moutinho C, Setien F, Villanueva A, González-Barca E, Muncunill J, Navarro JT, Piris MA, Cossio FP, Esteller M.

Haematologica. 2018 Nov;103(11):e537-e540. doi: 10.3324/haematol.2018.189241. Epub 2018 Jun 7. No abstract available.

5.

Apheresis activity in Spain: a survey of the Spanish Apheresis Group.

Lozano M, Cid J, Areal C, Romon I, Muncunill J; Spanish Apheresis Group.

Transfus Apher Sci. 2013 Dec;49(3):560-4. doi: 10.1016/j.transci.2013.09.008. Epub 2013 Sep 29.

PMID:
24148714
6.

Reducing the financial impact of pathogen inactivation technology for platelet components: our experience.

Girona-Llobera E, Jimenez-Marco T, Galmes-Trueba A, Muncunill J, Serret C, Serra N, Sedeño M.

Transfusion. 2014 Jan;54(1):158-68. doi: 10.1111/trf.12232. Epub 2013 May 9.

PMID:
23656485
7.

The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection.

Jimenez-Marco T, Riera C, Fisa R, Girona-Llobera E, Sedeño M, Goodrich RP, Pujol A, Guillen C, Muncunill J.

Blood Transfus. 2012 Oct;10(4):536-41. doi: 10.2450/2012.0178-11. Epub 2012 Jul 4. No abstract available.

8.

Pathogen inactivation technology applied to a blood component collected from an asymptomatic carrier of Leishmania infantum: a case report.

Jimenez-Marco T, Fisa R, Riera C, Girona-Llobera E, Sedeño M, Saura A, Iniesta L, Guillen C, Muncunill J.

Vox Sang. 2012 Nov;103(4):356-8. doi: 10.1111/j.1423-0410.2012.01622.x. Epub 2012 Jun 19.

PMID:
22712807
9.

A lesson to learn from Hemovigilance: The impact of nurses' transfusion practice on mistransfusion.

Jimenez-Marco T, Clemente-Marin G, Girona-Llobera E, Sedeño M, Muncunill J.

Transfus Apher Sci. 2012 Aug;47(1):49-55. doi: 10.1016/j.transci.2012.04.005. Epub 2012 May 28.

PMID:
22647684
10.

Usefulness of platelet (PLT) pathogen inactivation technology: a case of Sphingomonas paucimobilis inactivation in an apheresis PLT unit.

Jimenez-Marco T, Girona-Llobera E, Ruiz-Veramendi M, Sedeño M, Muncunill J.

Transfusion. 2010 Nov;50(11):2503-4. doi: 10.1111/j.1537-2995.2010.02805.x. No abstract available.

PMID:
21182632
11.

Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study.

del Río-Garma J, Alvarez-Larrán A, Martínez C, Muncunill J, Castellà D, de la Rubia J, Zamora C, Corral M, Viejo A, Peña F, Rodríguez-Vicente P, Contreras E, Arbona C, Ramírez C, Garcia-Erce JA, Alegre A, Mateo J, Pereira A.

Br J Haematol. 2008 Oct;143(1):39-45. doi: 10.1111/j.1365-2141.2008.07292.x. Epub 2008 Jul 14.

PMID:
18637799
12.

ADAMTS-13 activity and von Willebrand factor levels in methylene-blue photo-inactivated plasma processed by either the Springe method or an 'in house' system.

del Río-Garma J, Pereira A, Arroyo JL, Mateo J, Alvarez-Larrán A, Martínez C, Muncunill J, Barbolla L; Spanish Group of Apheresis (Grupo Español de Aféresis GEA).

Vox Sang. 2008 Aug;95(2):101-5. doi: 10.1111/j.1423-0410.2008.01077.x. Epub 2008 Jun 28.

PMID:
18557825
13.

Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain).

Riera C, Fisa R, López-Chejade P, Serra T, Girona E, Jiménez M, Muncunill J, Sedeño M, Mascaró M, Udina M, Gállego M, Carrió J, Forteza A, Portús M.

Transfusion. 2008 Jul;48(7):1383-9. doi: 10.1111/j.1537-2995.2008.01708.x. Epub 2008 Apr 18.

PMID:
18422844
14.

Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.

Alvarez-Larrán A, Del Río J, Ramírez C, Albo C, Peña F, Campos A, Cid J, Muncunill J, Sastre JL, Sanz C, Pereira A.

Vox Sang. 2004 May;86(4):246-51. Review.

PMID:
15144529
15.

In hereditary hemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebotomy.

Muncunill J, Vaquer P, Galmés A, Obrador A, Parera M, Bargay J, Besalduch J.

J Clin Apher. 2002;17(2):88-92.

PMID:
12210712
16.

Prevalence of the C282Y mutation for haemochromatosis on the Island of Majorca.

Guix P, Picornell A, Parera M, Tomás C, Muncunill J, Castro JA, Rossell J, Vaquer P, Ramon MM, Obrador A.

Clin Genet. 2000 Aug;58(2):123-8.

PMID:
11005145
17.

[Granulocyte transfusions. Return to the past].

Muncunill J.

Med Clin (Barc). 1999 May 1;112(15):574-6. Spanish. No abstract available.

PMID:
10365384
18.

Blood donor developing malaria more than one year after returning from a malarious area.

Castro E, Barea L, Muncunill J.

Haematologica. 1997 Nov-Dec;82(6):728. No abstract available.

19.

Acid elution of platelets HLA-class I antigens in the treatment of a refractory patient.

Castro E, Muncunill J, Barea L, González R, Fernández-Villalta MJ.

Br J Haematol. 1998 Jan;100(1):245-6. No abstract available.

PMID:
9450819
20.

Absence of seroconversion to hepatitis B and C among blood donors with elevated alanine aminotransferase.

Castro E, Gonzalez R, Barea L, Muncunill J.

Vox Sang. 1997;73(4):258. No abstract available.

PMID:
9407645
21.

[Infective morbidity of replacement therapy in congenital coagulation deficiencies and its effects on demand of coagulation factors].

Muncunill J, Forner N, Morey M, Galmés A, Vanrell L, Besalduch J.

Med Clin (Barc). 1991 Sep 14;97(8):287-91. Spanish.

PMID:
1943304
22.

[Blood donation in the Balearic Islands. Analysis of supply and demand of blood from 1982 to 1987].

Muncunill J, Sedeño M, Oliva E, Balanzat J, Serra J, Forteza A, Alvarez F.

Med Clin (Barc). 1991 Sep 14;97(8):281-6. Spanish.

PMID:
1943303
23.

Splenic irradiation as primary therapy for prolymphocytic leukaemia.

Muncunill J, Villá S, Domingo A, Doménech P, Arnaiz MD, Callis M.

Br J Haematol. 1990 Oct;76(2):305-6. No abstract available.

PMID:
2094335
24.

Post-remission therapy in acute myeloblastic leukemia. A randomized trial comparing early consolidation plus maintenance versus maintenance therapy alone.

Maldonado J, Gardella S, Rodriguez Fernandez JM, Parody R, Muncunill J, Vivancos P, Alonso C, Hernandez-Nieto L, Domingo A, Marin J, et al.

Acta Oncol. 1989;28(2):223-6.

PMID:
2660862
25.

[Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].

Muncunill J, Forteza A, Forner N, Forteza-Rei J.

Med Clin (Barc). 1986 Apr 5;86(13):565. Spanish. No abstract available.

PMID:
3012224
26.

[Post-traumatic arteriovenous fistula, secondary to a vascular wound from a firearm. Presentation of a case].

Muñoz A, Vidal W, Muncunill J, Oller E.

Angiologia. 1984 Sep-Oct;36(5):228-31. Spanish. No abstract available.

PMID:
6476468
27.

[Isotopic gamma phlebography: features and indications].

Torres-Torres R, Vidal-Conde V, Setoain J, Cedó J, Muñoz A, Muncunill J.

Angiologia. 1981 Jan-Feb;33(1):1-13. Spanish. No abstract available.

PMID:
7469115
28.

Chronic myelomonocytic leukemia associated with hereditary pyruvate kinase deficiency and multiple acquired erythrocyte abnormalities.

Vives-Corrons JL, Florensa L, Muncunill J, Nomdedeu B, Rozman C.

Acta Haematol. 1979;61(3):168-74.

PMID:
108894
29.

[Angiogammography (99m Tc O4) for the study of the aortoiliac sector in the chronic ischemic syndrome of the lower extremities].

Vidal Conde V, Setoain J, Torres Torres R, Cedo J, Muñoz Vicen A, Herranz R, Romero G, Muncunill J, Apezteguia C.

Angiologia. 1978 May-Jun;30(3):87-97. Spanish. No abstract available.

PMID:
655458
30.

[Secondary myelofibrosis and/or osteosclerosis. An assessment of 400 biopsies (author's transl)].

Hernández Nieto L, Muncunill J, Rozman C, Fabregues M, Feliú E, Grañena A, Montserrat-Costa E, Nomdedeu B.

Sangre (Barc). 1978;23(4):402-10. Spanish. No abstract available.

PMID:
705562
31.

[The effectiveness of granulocyte transfusions in the treatment of severe injections in granulocytopenic patients. A controlled trial (author's transl)].

Grañena A, Aranalde JM, Feliu E, Muncunill J, Montserrat E, Hernandez Nieto L, Rozman C.

Sangre (Barc). 1978;23(3):291-7. Spanish. No abstract available.

PMID:
675453
32.

Bone-marrow patterns and clinical staging in chronic lymphocytic leukaemia.

Hernandez-Nieto L, Montserrat-Costa E, Muncunill J, Rozman C.

Lancet. 1977 Jun 11;1(8024):1269. No abstract available.

PMID:
68376
33.

[Periarteritis nodosa. Apropos of 12 cases].

Morell F, Richart C, Morera J, Muncunill J, Guardia J.

Rev Clin Esp. 1976 Aug 15;142(3):217-22. Spanish. No abstract available.

PMID:
9671

Supplemental Content

Loading ...
Support Center